Does RAVULIZUMAB-CWVZ Cause Condition aggravated? 138 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Condition aggravated have been filed in association with RAVULIZUMAB-CWVZ. This represents 1.4% of all adverse event reports for RAVULIZUMAB-CWVZ.
138
Reports of Condition aggravated with RAVULIZUMAB-CWVZ
1.4%
of all RAVULIZUMAB-CWVZ reports
13
Deaths
40
Hospitalizations
How Dangerous Is Condition aggravated From RAVULIZUMAB-CWVZ?
Of the 138 reports, 13 (9.4%) resulted in death, 40 (29.0%) required hospitalization, and 4 (2.9%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Condition aggravated Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST